Evolution of the Average Target: Amarin Corporation plc

Evolution of the Target Price: Amarin Corporation plc

Changes in Analyst Recommendations: Amarin Corporation plc

6f602fe0b775032c34.cZuJXWkVMUR-0ah6W_S9sdEBG3RWwAOCgZjLEcT7jgc.O9f-aztXdxEQh-ocA7na571xQx41uVn28sGjUK6yzUlA-MQfXSFWEUuH7Q~8c0357c2f7b7791dcc6790e483a09640
27/10/25 Amarin issues statement supporting FDA's action to revise labeling for fenofibrate drugs reinforcing a lack of cardiovascular benefit RE
25/06/25 RBC Ups Recordati's Price Target on Cardiovascular Drug European Licensing Deal MT
25/10/23 Jefferies Downgrades Amarin to Hold From Buy, Cuts Price Target to $1 From $3 MT
19/07/23 Northland Adjusts Price Target on Amarin to $1.25 From $2, Maintains Market Perform Rating MT
06/01/23 Jefferies Upgrades Amarin to Buy From Hold, Adjusts Price Target to $3 From $1.30 MT
19/10/22 SVB Securities Adjusts Amarin's Price Target to $2 From $3, Maintains Market Perform Rating MT
06/05/22 JPMorgan Downgrades Amarin to Underweight From Neutral MT
05/05/22 HC Wainwright Lowers Amarin to Neutral From Buy, Price Target to $3 From $10 MT
05/05/22 SVB Leerink Downgrades Amarin to Market Perform From Outperform, Adjusts Price Target to $3 From $10 MT
05/05/22 Northland Downgrades Amarin to Market Perform From Outperform, Adjusts Price Target to $2 From $9 MT
16/02/22 SVB Leerink Adjusts Amarin's Price Target to $10 from $11, Maintains Outperform Rating MT
31/01/22 SVB Leerink Adjusts Amarin's Price Target to $11 from $12, Keeps Outperform Rating MT
12/05/21 AMARIN : Goldman Sachs Downgrades Amarin to Sell From Neutral, Adjusts Price Target to $5 From $6 MT
01/02/21 AMARIN : SVB Leerink Adjusts Price Target on Amarin to $16 From $12, Maintains Outperform Rating MT
23/12/20 AMARIN : Goldman Sachs Adjusts Amarin's Price Target to $6 From $8, Maintains Neutral Rating MT
07/12/20 AMARIN : Citigroup Adjusts Amarin's Price Target to $7 from $12, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- -21.43%
+10.79%
+23.51%
+35.78%
+90.61%
+41.85%
+35.91%
-9.62%
-21.53%
+31.01%
Average +21.69%
Weighted average by Cap. +26.20%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
15.91USD
Average target price
12.50USD
Spread / Average Target
-21.43%
High Price Target
13.00USD
Spread / Highest target
-18.29%
Low Price Target
12.00USD
Spread / Lowest Target
-24.58%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Jefferies & Co.
Northland Securities
SVB Securities LLC
JPMorgan Chase
SVB Leerink
HC Wainwright
Goldman Sachs
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
15.91USD
Average target price
12.50USD
Spread / Average Target
-21.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRN Stock
  4. Consensus Amarin Corporation plc